Cargando…

Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More

BACKGROUND: Gitelman's and Bartter's syndromes (GS/BS) are rare genetic tubulopathies characterized by electrolyte imbalance and activation of the renin-angiotensin-aldosterone system (RAAS). These syndromes have intriguing biochemical and hormonal abnormalities that lead them to be protec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravarotto, Verdiana, Bertoldi, Giovanni, Stefanelli, Lucia Federica, Nalesso, Federico, Calò, Lorenzo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677844/ https://www.ncbi.nlm.nih.gov/pubmed/35858584 http://dx.doi.org/10.1159/000526070

Ejemplares similares

Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes
por: Sgarabotto, Luca, et al.
Publicado: (2023)

The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes
por: Francini, Francesco, et al.
Publicado: (2021)

Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
por: Bertoldi, Giovanni, et al.
Publicado: (2021)

ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes
por: Calò, Lorenzo A., et al.
Publicado: (2021)

Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies
por: Ravarotto, Verdiana, et al.
Publicado: (2022)

Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach
por: Rigato, Matteo, et al.
Publicado: (2022)

Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
por: Calò, Lorenzo A., et al.
Publicado: (2020)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
por: Bamgbola, Oluwatoyin Fatai, et al.
Publicado: (2021)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
por: Bamgbola, Oluwatoyin Fatai, et al.
Publicado: (2020)

Clinical and Genetic Characterization of Patients with Bartter and Gitelman Syndrome
por: Palazzo, Viviana, et al.
Publicado: (2022)

Bartter and Gitelman syndromes: Questions of class
por: Besouw, Martine T. P., et al.
Publicado: (2019)

Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians
por: Nuñez-Gonzalez, Laura, et al.
Publicado: (2021)

Clinical and diagnostic features of Bartter and Gitelman syndromes
por: Walsh, Patrick R, et al.
Publicado: (2018)

The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study
por: Bertoldi, Giovanni, et al.
Publicado: (2022)

Far di Necessità Virtù, using rare tubulopathies, Gitelman’s and Bartter’s syndromes, to inform the fight against COVID-19
por: Calò, Lorenzo A., et al.
Publicado: (2021)

The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease
por: Ravarotto, Verdiana, et al.
Publicado: (2021)

Are the Clinical Presentations (Phenotypes) of Gitelman’s and Bartter’s Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their “pH” Enotype?
por: Calò, Lorenzo A, et al.
Publicado: (2020)

Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement?
por: Ravarotto, Verdiana, et al.
Publicado: (2018)

Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation
por: Stefanelli, Lucia Federica, et al.
Publicado: (2023)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
por: Bertoldi, Giovanni, et al.
Publicado: (2023)

Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects
por: Seyberth, Hannsjörg W., et al.
Publicado: (2011)

Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study
por: Verploegen, Maartje F A, et al.
Publicado: (2022)

Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients
por: Calò, Lorenzo A., et al.
Publicado: (2020)

A novel mutation of CLCNKB in a Korean patient of mixed phenotype of Bartter-Gitelman syndrome
por: Cho, Hee-Won, et al.
Publicado: (2016)

Diuretic loading test and use of Bartter's Normogram in diagnosing a case of Gitelman's syndrome: Relook into pathophysiology
por: Goswami, R. P., et al.
Publicado: (2011)

Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome
por: Tang, Wangna, et al.
Publicado: (2022)

The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing
por: Stevenson, Mark, et al.
Publicado: (2022)

ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements
por: Seccia, Teresa M., et al.
Publicado: (2020)

Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?
por: Ravarotto, Verdiana, et al.
Publicado: (2018)

Mixed Bartter-Gitelman syndrome: an inbred family with a heterogeneous phenotype expression of a novel variant in the CLCNKB gene
por: Al-Shibli, Amar, et al.
Publicado: (2014)

Identification of compound mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome exhibiting Bartter syndrome-liked phenotypes
por: Dong, Bingzi, et al.
Publicado: (2020)

Endothelin‐1 Drives Epithelial‐Mesenchymal Transition in Hypertensive Nephroangiosclerosis
por: Seccia, Teresa M., et al.
Publicado: (2016)

Gitelman Syndrome and Hypertension: A Case Report
por: Shaukat, Hiba, et al.
Publicado: (2023)

The Supporting Role of Combined and Sequential Extracorporeal Blood Purification Therapies in COVID-19 Patients in Intensive Care Unit
por: Nalesso, Federico, et al.
Publicado: (2022)

Slow Continuous Ultrafiltration in Regional Citrate Anticoagulation Performed with a Standard Fluid Infusion Central Venous Catheter in Intensive Care Unit for Fluid Overload in Acute on Chronic Heart Failure: A Case Report
por: Nalesso, Federico, et al.
Publicado: (2023)

The genetic spectrum of Gitelman(-like) syndromes
por: Schlingmann, Karl P., et al.
Publicado: (2022)

The patient safety in extracorporeal blood purification treatments of critical patients
por: Nalesso, Federico, et al.
Publicado: (2022)

Paradoxical hypertension and salt wasting in Type II Bartter syndrome
por: Chan, Winnie Kwai-yu, et al.
Publicado: (2012)

Gitelman syndrome
por: Knoers, Nine VAM, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fbbsd4mln5j6dpqobirfmtqo8s